Stocktoria
ACHIEVE LIFE SCIENCES, INC. ACHV
Nasdaq · XNAS · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1995-10-12
ACHIEVE LIFE SCIENCES, INC. statistics & valuation
Market cap$618.0M
P / B28.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -130.8% | -103.1% | -153.9% | -141.3% | -69.8% |
| Return on equity | -254.0% | -190.6% | 2059.0% | -510.1% | -118.2% |
| Current ratio | 4.39 | 5.46 | 0.82 | 1.27 | 9.80 |
Source: SEC EDGAR filings · CIK 0000949858 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.